Demonstrating a reduced capacity for removal of fluid from cerebral white matter and hypoxia in areas of white matter hyperintensity associated with age and dementia.


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
08 08 2020
Historique:
received: 17 06 2020
accepted: 01 08 2020
entrez: 11 8 2020
pubmed: 11 8 2020
medline: 1 6 2021
Statut: epublish

Résumé

White matter hyperintensities (WMH) occur in association with dementia but the aetiology is unclear. Here we test the hypothesis that there is a combination of impaired elimination of interstitial fluid from the white matter together with a degree of hypoxia in WMH. One of the mechanisms for the elimination of amyloid-β (Aβ) from the brain is along the basement membranes in the walls of capillaries and arteries (Intramural Peri-Arterial Drainage - IPAD). We compared the dynamics of IPAD in the grey matter of the hippocampus and in the white matter of the corpus callosum in 10 week old C57/B16 mice by injecting soluble Aβ as a tracer. The dynamics of IPAD in the white matter were significantly slower compared with the grey matter and this was associated with a lower density of capillaries in the white matter. Exposing cultures of smooth muscle cells to hypercapnia as a model of cerebral hypoperfusion resulted in a reduction in fibronectin and an increase in laminin in the extracellular matrix. Similar changes were detected in the white matter in human WMH suggesting that hypercapnia/hypoxia may play a role in WMH. Employing therapies to enhance both IPAD and blood flow in the white matter may reduce WMH in patients with dementia.

Identifiants

pubmed: 32771063
doi: 10.1186/s40478-020-01009-1
pii: 10.1186/s40478-020-01009-1
pmc: PMC7414710
doi:

Substances chimiques

Amyloid beta-Peptides 0
Fibronectins 0
Laminin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

131

Subventions

Organisme : Medical Research Council
ID : G1000691
Pays : United Kingdom
Organisme : MRC CFAS
ID : MRC U.1052.00.0013
Pays : International
Organisme : MRC CFAS
ID : MRC/G9901400
Pays : International
Organisme : Medical Research Council
ID : G0601022
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9901400
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L022656/1
Pays : United Kingdom

Références

Acta Neuropathol. 2018 Jul;136(1):139-152
pubmed: 29754206
Brain Res. 2018 Dec 1;1700:78-85
pubmed: 30006296
Acta Neuropathol. 2010 Mar;119(3):277-90
pubmed: 20155424
Exp Neurol. 2013 Dec;250:270-81
pubmed: 24103194
Matrix Biol. 2002 Aug;21(5):399-414
pubmed: 12225805
Neuropathology. 2003 Jun;23(2):111-8
pubmed: 12777099
Nat Immunol. 2017 Feb;18(2):123-131
pubmed: 28092374
Brain Pathol. 2015 Jan;25(1):63-78
pubmed: 25521178
Neuropathol Appl Neurobiol. 2011 Feb;37(1):75-93
pubmed: 20946241
Brain Res Bull. 1981 Nov;7(5):519-79
pubmed: 7317796
Front Aging Neurosci. 2016 Sep 27;8:223
pubmed: 27729857
J Am Heart Assoc. 2015 Jun 23;4(6):001140
pubmed: 26104658
Acta Neuropathol Commun. 2019 Feb 7;7(1):16
pubmed: 30732655
Radiat Res. 1987 May;110(2):161-72
pubmed: 3575649
Physiol Rev. 2005 Jul;85(3):979-1000
pubmed: 15987800
Acta Neuropathol. 2009 Jan;117(1):1-14
pubmed: 19002474
BMC Bioinformatics. 2017 Nov 29;18(1):529
pubmed: 29187165
Acta Neuropathol. 2011 Apr;121(4):431-43
pubmed: 21259015
J Neuroinflammation. 2012 Jul 03;9:159
pubmed: 22759265
J Cereb Blood Flow Metab. 2019 Jan;39(1):3-19
pubmed: 30226080
Am J Physiol. 1984 Jun;246(6 Pt 2):F835-44
pubmed: 6742132
Brain Pathol. 2015 Jan;25(1):35-43
pubmed: 25521175
J Cell Biol. 1998 May 18;141(4):1019-30
pubmed: 9585419
Acta Neuropathol. 2017 Sep;134(3):459-473
pubmed: 28638989
J Cereb Blood Flow Metab. 2016 Jan;36(1):143-57
pubmed: 25853907
Neuron. 2020 Feb 5;105(3):549-561.e5
pubmed: 31810839
Acta Neuropathol. 2016 May;131(5):725-36
pubmed: 26975356
J Neuropathol Exp Neurol. 2003 Feb;62(2):154-61
pubmed: 12578225
Acta Neuropathol. 2016 Sep;132(3):317-38
pubmed: 27522506
Neuroimage Clin. 2019;23:101839
pubmed: 31078937
J Neurosci. 2004 Oct 20;24(42):9282-90
pubmed: 15496664
J Neuropathol Exp Neurol. 1971 Oct;30(4):613-26
pubmed: 5135016
PLoS One. 2019 Jan 25;14(1):e0210888
pubmed: 30682074
Acta Neuropathol. 2015 May;129(5):763-6
pubmed: 25814152
Front Neurosci. 2017 Aug 24;11:475
pubmed: 28883786
Neuropathol Appl Neurobiol. 2013 Oct;39(6):593-611
pubmed: 23489283
Aging Cell. 2013 Apr;12(2):224-36
pubmed: 23413811
Nat Rev Neurol. 2015 Aug;11(8):457-70
pubmed: 26195256
J Cereb Blood Flow Metab. 2013 Jul;33(7):1050-7
pubmed: 23532085
Exp Neurol. 1974 Oct;45(1):50-60
pubmed: 4137563
Clin Sci (Lond). 2018 Apr 30;132(8):851-868
pubmed: 29712883
J Neurooncol. 1997 May;32(3):193-201
pubmed: 9049880
Brain. 1969;92(4):819-28
pubmed: 5364012
Biochim Biophys Acta. 2016 May;1862(5):1037-46
pubmed: 26327684
Ann N Y Acad Sci. 1986;481:123-34
pubmed: 3468852
Neuropathol Appl Neurobiol. 2008 Apr;34(2):131-44
pubmed: 18208483
Front Aging Neurosci. 2019 Jan 23;11:1
pubmed: 30740048
Angiogenesis. 2018 May;21(2):251-266
pubmed: 29299782
Acta Neuropathol. 2012 Mar;123(3):381-94
pubmed: 22170742
J Mol Neurosci. 2016 Jul;59(3):317-25
pubmed: 26590999
AJNR Am J Neuroradiol. 2017 May;38(5):928-934
pubmed: 28364004
Neuropathol Appl Neurobiol. 2004 Aug;30(4):385-95
pubmed: 15305984

Auteurs

Matthew MacGregor Sharp (M)

Faculty of Medicine, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.

Satoshi Saito (S)

Faculty of Medicine, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.

Abby Keable (A)

Faculty of Medicine, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.

Maureen Gatherer (M)

Faculty of Medicine, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.

Roxana Aldea (R)

Faculty of Medicine, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.
Roche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.

Nivedita Agarwal (N)

Hospital Santa Maria del Carmine, Rovereto, Italy.

Julie E Simpson (JE)

Sheffield Institute for Translational Neurosciences, University of Sheffield, Sheffield, UK.

Stephen B Wharton (SB)

Sheffield Institute for Translational Neurosciences, University of Sheffield, Sheffield, UK.

Roy O Weller (RO)

Faculty of Medicine, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.

Roxana O Carare (RO)

Faculty of Medicine, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK. rcn@soton.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH